Butterfly Network, Inc.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Joseph M. DeVivo
- Full Time Employees
- 220
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- 1600 District Avenue Burlington MA United States 01803
- IPO Date
- May 26, 2020
- CIK
- 0001804176
- Website
- butterflynetwork.com
- Similar Companies
- Business
- Butterfly Network, Inc. (NYSE: BFLY) develops, manufactures, and commercializes handheld ultrasound-on-chip technology and related software solutions for point-of-care medical imaging. The company offers whole-body ultrasound probes including Butterfly iQ3, Butterfly iQ+, Butterfly iQ+ Bladder, and Butterfly iQ+ Vet; cloud-based software such as Compass for enterprise workflow integration, TeleGuidance, and AI-powered tools for image guidance and interpretation; educational platforms comprising in-app tutorials, ScanLab app, Butterfly Academy courses, and Butterfly Certified programs; and professional services for large-scale deployments. Butterfly Network, founded in 2011 and headquartered in Burlington, Massachusetts, operates primarily in the United States with international sales in regions including Europe, Asia, Africa, Australia, Indonesia, the Netherlands, and Belgium, targeting healthcare professionals, hospitals, clinics, veterinary practices, health systems, and medical education programs. In recent developments, the company launched the iQ3 ultrasound probe gaining traction in the U.S. and Europe with 55% product revenue growth; formed Octiv as a wholly-owned subsidiary to extend its Ultrasound-on-Chip technology into new sectors; expanded into new markets including Indonesia, the Netherlands, and Belgium driving 36% international revenue increase; initiated a Butterfly HomeCare pilot for AI-powered chronic care management with a Medicare Advantage provider; raised $75.6 million in post-IPO equity funding in January 2025 to enhance product lines and enter additional markets; and reported 5% revenue growth in Q3 2025 alongside advancements in AI tools for aortic valve imaging and gestational age assessment.
Company News
Butterfly Network Q3 Earnings Call Highlights
Butterfly Network, Inc. (BFLY) Q3 2026 Earnings Call Transcript
Butterfly Network, Inc. (BFLY) Reports Q3 Loss, Beats Revenue Estimates
Butterfly Network Reports Third Quarter 2026 Financial Results
Butterfly Network to Present at UBS Global Healthcare Conference on November 10, 2026
The Edward Via College of Osteopathic Medicine (VCOM) and Butterfly Network Announce Long-Term Alliance to Build New Model for Ultrasound Education
Butterfly Network (NYSE:BFLY) Shares Up 6.6% – Here’s What Happened
Beyond Elon Musk's Neuralink: Two Public Stocks With a Stake in the Brain Race
Butterfly Network to Report Third Quarter 2026 Financial Results on October 29, 2026
Butterfly Network Lands Multi-Year Bridge Neurotech Deal
Bridge Neurotech and Butterfly Network Announce Partnership to Develop Fully Non-Invasive Brain-Computer Interface
Butterfly Network (NYSE:BFLY) Sets New 12-Month High – Should You Buy?
Critical Review: Zimmer Biomet (NYSE:ZBH) and Butterfly Network (NYSE:BFLY)
Butterfly Network Appoints Mike Noonen to Board of Directors
Neuralink Stock: How to Invest Before the IPO
Mendaera's Focalist™ System Now Compatible with Butterfly's Ultrasound-on-Chip™ Technology
Butterfly Network (NYSE:BFLY) Shares Gap Up After Analyst Upgrade
Butterfly Stock Retreats: What's Going On Today?
Butterfly Network (BFLY) Surges 22.0%: Is This an Indication of Further Gains?
Executive Waves Goodbye to Nearly 14,000 Shares, Valued at More Than $100,000